Thus, ST8SIA6 co-expressed genes and ST8SIA6 may drive multiple oncogenic pathways with abnormal glycosylation in cancer cells and serve as a potential tumor biomarker for colon cancer. Here, ST8SIA6 is linked to colonic neoplasm.